Connecticut Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $744K | Sell |
4,009
-10,115
| -72% | -$1.88M | 0.04% | 180 |
|
|
2025
Q1 | $2.17M | Buy |
14,124
+10,413
| +281% | +$1.6M | 0.11% | 86 |
|
|
2024
Q4 | $660K | Buy |
3,711
+57
| +2% | +$10.1K | 0.03% | 166 |
|
|
2024
Q3 | $722K | Buy |
3,654
+1,492
| +69% | +$295K | 0.03% | 188 |
|
|
2024
Q2 | $371K | Buy |
2,162
+184
| +9% | +$31.6K | 0.02% | 241 |
|
|
2024
Q1 | $360K | Sell |
1,978
-35
| -2% | -$6.37K | 0.02% | 251 |
|
|
2023
Q4 | $312K | Buy |
2,013
+248
| +14% | +$38.4K | 0.02% | 264 |
|
|
2023
Q3 | $263K | Buy |
1,765
+200
| +13% | +$29.8K | 0.02% | 246 |
|
|
2023
Q2 | $211K | Sell |
1,565
-10
| -0.6% | -$1.35K | 0.01% | 251 |
|
|
2023
Q1 | $251K | Buy |
+1,575
| New | +$251K | 0.02% | 219 |
|
|
2021
Q2 | – | Sell |
-2,580
| Closed | -$279K | – | 193 |
|
|
2021
Q1 | $279K | Buy |
2,580
+2
| +0.1% | +$216 | 0.03% | 132 |
|
|
2020
Q4 | $276K | Buy |
2,578
+2
| +0.1% | +$214 | 0.03% | 157 |
|
|
2020
Q3 | $226K | Buy |
+2,576
| New | +$226K | 0.02% | 182 |
|